Birgit Lahme

1.9k total citations
35 papers, 1.6k citations indexed

About

Birgit Lahme is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Birgit Lahme has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Hepatology and 9 papers in Surgery. Recurrent topics in Birgit Lahme's work include Liver physiology and pathology (17 papers), Connective Tissue Growth Factor Research (12 papers) and TGF-β signaling in diseases (10 papers). Birgit Lahme is often cited by papers focused on Liver physiology and pathology (17 papers), Connective Tissue Growth Factor Research (12 papers) and TGF-β signaling in diseases (10 papers). Birgit Lahme collaborates with scholars based in Germany and China. Birgit Lahme's co-authors include Axel M. Gressner, O Gressner, Ralf Weiskirchen, K. Mangasser-Stephan, Steven Dooley, Bert Delvoux, Hans Georg Mannherz, Sydney L. Roth, Steffen K. Meurer and Lidia Tihaa and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

Birgit Lahme

35 papers receiving 1.6k citations

Peers

Countries citing papers authored by Birgit Lahme

Since Specialization

Citations

This map shows the geographic impact of Birgit Lahme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Lahme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Lahme more than expected).

Fields of papers citing papers by Birgit Lahme

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Lahme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Lahme. The network helps show where Birgit Lahme may publish in the future.

Co-authorship network of co-authors of Birgit Lahme

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Lahme. A scholar is included among the top collaborators of Birgit Lahme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Lahme. Birgit Lahme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor β actions in hepatocytes—But without modulating bone morphogenetic protein 7 signaling† 2009 ·Hepatology ·O Gressner, Birgit Lahme, (unknown), (unknown), Ralf Weiskirchen, Axel M. Gressner	48
2	Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis 2009 ·Journal of Viral Hepatitis ·(unknown), Frank Tacke, O Gressner, (unknown), Birgit Lahme, Alfred Janetzko, T. Wiederholt, Thomas Berg, Tobias Müller, Christian Trautwein, Axel M. Gressner, Ralf Weiskirchen	47
3	Elevated concentrations of 15‐deoxy‐Δ^12,14‐prostaglandin J₂ in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor γ‐inducing drugs 2009 ·Liver International ·O Gressner, Chunfang Gao, (unknown), Birgit Lahme, (unknown), Thomas Berg, Tobias Müller, Axel M. Gressner	9
4	Intracrine signalling of activin A in hepatocytes upregulates connective tissue growth factor (CTGF/CCN2) expression 2008 ·Liver International ·O Gressner, Birgit Lahme, (unknown), (unknown), Ralf Weiskirchen, Axel M. Gressner	30
5	Activation of TGF‐β within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor 2008 ·Journal of Cellular and Molecular Medicine ·O Gressner, Birgit Lahme, (unknown), (unknown), Jens Herrmann, Ralf Weiskirchen, Axel M. Gressner	52
6	Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: Relationship to S-100B levels and blood–brain barrier function 2008 ·Clinica Chimica Acta ·O Gressner, (unknown), (unknown), (unknown), Birgit Lahme, Axel M. Gressner	15
7	Loss of TGF-β dependent growth control during HSC transdifferentiation 2007 ·Biochemical and Biophysical Research Communications ·(unknown), Birgit Lahme, Axel M. Gressner, Nadja M. Meindl‐Beinker, Steven Dooley	23
8	Evaluation of hepatotropic targeting properties of allogenic and xenogenic erythrocyte ghosts in normal and liver‐injured rats 2007 ·Liver International ·O Gressner, Birgit Lahme, Martin Koch, Axel M. Gressner	5
9	Differential effects of TGF-β on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes 2007 ·Journal of Hepatology ·O Gressner, Birgit Lahme, (unknown), Axel M. Gressner, Ralf Weiskirchen	122
10	Elevation of Nε-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis 2005 ·Clinical Biochemistry ·Eray Yagmur, Frank Tacke, Claudia Weiß, Birgit Lahme, Michael P. Manns, Paul Kiefer, Christian Trautwein, Axel M. Gressner	63
11	N-Acetyl-l-cysteine suppresses TGF-β signaling at distinct molecular steps: The biochemical and biological efficacy of a multifunctional, antifibrotic drug 2005 ·Biochemical Pharmacology ·Steffen K. Meurer, Birgit Lahme, Lidia Tihaa, Ralf Weiskirchen, Axel M. Gressner	54
12	Identification of Endoglin in Rat Hepatic Stellate Cells 2004 ·Journal of Biological Chemistry ·Steffen K. Meurer, Lidia Tihaa, Birgit Lahme, Axel M. Gressner, Ralf Weiskirchen	51
13	Expression and Matrix Deposition of Latent Transforming Growth Factor β Binding Proteins in Normal and Fibrotic Rat Liver and Transdifferentiating Hepatic Stellate Cells in Culture 2001 ·Hepatology ·K Breitkopf, Birgit Lahme, Carmen G. Tag, A Gressner	46
14	Expression of isoforms and splice variants of the latent transforming growth factor β binding protein (LTBP) in cultured human liver myofibroblasts 2001 ·Liver International ·K. Mangasser-Stephan, Carsten Gartung, Birgit Lahme, Axel M. Gressner	29
15	Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts 2000 ·Hepatology ·Steven Dooley, Bert Delvoux, Birgit Lahme, K. Mangasser-Stephan, Axel M. Gressner	186
16	Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells 1999 ·Journal of Hepatology ·Hans Sprenger, (unknown), Holger Garn, Birgit Lahme, Diethard Gemsa, A Gressner	43
17	Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble fas ligand 1998 ·Hepatology ·Wenrong Gong, Adalı́ Pecci, Sydney L. Roth, Birgit Lahme, Miguel Beato, Axel M. Gressner	85
18	Attenuation of TGF-β-Induced Apoptosis in Primary Cultures of Hepatocytes by Calpain Inhibitors 1997 ·Biochemical and Biophysical Research Communications ·Axel M. Gressner, Birgit Lahme, Sydney L. Roth	41
19	Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells 1997 ·Gastroenterology ·Hans Sprenger, Andreas M. Kaufmann, Holger Garn, Birgit Lahme, (unknown), (unknown)	73
20	Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor β 1996 ·Hepatology ·Axel M. Gressner, Bernhard Polzar, Birgit Lahme, Hans Georg Mannherz	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact